MassIVE MSV000093936

Partial Public

Unbiased quantification of core-fucosylation stoichiometry reveals its role in cancer progression and embryonic development

Subscribe Comment Convert Spectra Add Reanalysis

Description

Core fucosylation on N-glycosylation plays pivotal roles in regulating ligand binding and cell adhesion, and it is critical to investigate the level of core fucosylation changes in biological processes to further understand its functions. Nevertheless, an unbiased method to globally measure the core fucosylation stoichiometry has not been developed. Here, we devised an approach combining selective enrichment, enzymatic reactions, and multiplexed proteomics to unbiasedly quantify the core fucosylation stoichiometry in multiple biological systems. It was found that the core fucosylation stoichiometry is the lowest in the lysosome and the highest in the extracellular matrix. Moreover, different core fucosylation stoichiometry was observed for the glycosites dwell in various protein domains, and the more aromatic and hydrophobic residues neighboring the glycosites is associated with lower core fucosylation stoichiometry. The method was applied to quantify the core fucosylation stoichiometry change in EMT. It was found that although the overall core fucosylation stoichiometry was similar in the epithelial and mesenchymal states, some glycoproteins involved in extracellular matrix organization and ligand recognition displayed dramatic stoichiometry change, which suggests the regulatory role of core fucosylation in EMT. Breast cell lines (MCF10A, MCF7, and MDA-MB-231) were used as models for cancer progression, and we found that a significant increase of core fucosylation stoichiometry in MDA-MB-231 cells (>80%) comparing to the noncancerous MCF10A cells, but the overall stoichiometry was similar for MCF7 and MCF10A. Moreover, the core fucosylation stoichiometry of an embryonic human kidney cell line, HEK293T was compared with a kidney cancer cell line A498. It was found that the average stoichiometry in HEK293T was the highest among all cell lines quantified in this work (~84%) and was much higher than that of A498 cells, indicating core fucosylation may be an influential regulator in embryonic development. Without any sample restriction, this method can serve as a valuable tool for investigating core fucosylation change in various biological processes. [doi:10.25345/C5J960M79] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Core fucosylation ; N-glycosylation ; Stoichiometry ; Cancer ; EMT ; Embryonic development ; Multiplexed proteomics

Contact

Principal Investigators:
(in alphabetical order) 		Ronghu Wu, Georgia Institute of Technology, United States
Submitting User: xusenhan
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.